Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    All News

    Brief: Genmab Announces Johnson & Johnson Decision Regarding HEXABODY-CD38

    Picture of Genmab A/S logoGenmab A/S
    10/03/2025 15:57
    March 10 (Reuters) - Genmab A/S GMAB.CO:

GENMAB ANNOUNCES JOHNSON & JOHNSON DECISION REGARDING HEXABODY-CD38

WILL NOT PURSUE FURTHER CLINICAL DEVELOPMENT OF HEXABODY-CD38

JOHNSON & JOHNSON HAS DECIDED THAT IT WILL NOT EXERCISE ITS OPTION TO RECEIVE A WORLDWIDE LICENSE TO DEVELOP, MANUFACTURE AND COMMERCIALIZE HEXABODY-CD38

Source text: ID:nGNEbZt6Ft

Further company coverage: GMAB.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

    Recent news on Genmab A/S

    See all news